category,datetime,headline,id,image,related,source,summary,url
company,1769122803,Why Gilead Sciences (GILD) Outpaced the Stock Market Today,138220297,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,GILD,Yahoo,"Gilead Sciences (GILD) reached $131.14 at the closing of the latest trading day, reflecting a +1.57% change compared to its last close.",https://finnhub.io/api/news?id=ce262b5f384e2bf425d3ff493e4a0657ff8c5db8193feb49530368e90b168dd8
company,1769101200,4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer,138205891,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,GILD,Yahoo,"4D Path’s QPOR™ Platform Selected to Predict Patients’ Responses to TherapyNEWTON, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- 4D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory biomarker collaborator in the Phase II DAD-IO clinical study (NCT04724018) led by Dana-Farber Cancer Institute and supported by Gilead Sciences, Inc. This high-profile study is evalu",https://finnhub.io/api/news?id=d519722a430166cd826e99090a64d0bf0075c147c33083a42a4d4cf55cc68436
company,1769099700,Gilead Sciences Inc. stock outperforms competitors on strong trading day,138234946,,GILD,MarketWatch,Gilead Sciences Inc. stock outperforms competitors on strong trading day,https://finnhub.io/api/news?id=c86117b80dcfe952754e00bf651a2bb61bc9cc5ea21dfddfd93ae0616b879116
